"Founded in 1971, RWJ University Hospital Hamilton, an RWJ Barnabas Health facility, provides a network of comprehensive health care services including hospital care, emergency, prevention and wellness, primary care, cancer care, cancer treatment, infusion center, orthopedic and spine care, neuroscience and neurology, bariatric & surgical weight loss, rehabilitation, physical therapy, balance & hearing center, community education and better health & specialty practices as well as outpatient diagnostic & treatment services to the community. RWJ University Hospital Hamilton is an affiliate partner of Rutgers Cancer Institute of New Jersey in New Brunswick, the only National Cancer Institute‐designated comprehensive cancer center in New Jersey."

During the past decade, RWJBarnabas Health - Robert Wood Johnson University Hospital conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "RWJBarnabas Health - Robert Wood Johnson University Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 4 trials as a collaborator and "Rutgers Cancer Institute of New Jersey" with 4 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "RWJBarnabas Health - Robert Wood Johnson University Hospital" are "Advanced Non-small Cell Lung Cancer" (1 trials), "Breast Cancer" (1 trials), "Breast Cancer, Early-Onset" (1 trials), "Cardiac Toxicity" (1 trials) and "Colorectal Cancer" (1 trials). Many other conditions were trialed in "RWJBarnabas Health - Robert Wood Johnson University Hospital" in a lesser frequency.

Most popular intervention types in "RWJBarnabas Health - Robert Wood Johnson University Hospital" are "Drug" (8 trials), "Other" (2 trials), "Biological" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (1 trials), "Carboplatin" (1 trials), "EXTERNAL BEAM RADIATION" (1 trials), "External beam boost" (1 trials) and "Folfirinox alternating with Gemcitabine-nab-Paclitaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "RWJBarnabas Health - Robert Wood Johnson University Hospital" are 8 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "RWJBarnabas Health - Robert Wood Johnson University Hospital". undefined are not yet recruiting, 5 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in RWJBarnabas Health - Robert Wood Johnson University Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in RWJBarnabas Health - Robert Wood Johnson University Hospital, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".